Metsä Board Oyj (METSA.HE)

Revenue growth at 50-75% of VALMT.HE's 9.24%. Martin Whitman would worry about competitiveness or product relevance.

Negative gross profit growth while VALMT.HE is at 8.89%. Joel Greenblatt would examine cost competitiveness or demand decline.

Negative EBIT growth while VALMT.HE is at 19.59%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.

Negative operating income growth while VALMT.HE is at 19.59%. Joel Greenblatt would press for urgent turnaround measures.

Negative net income growth while VALMT.HE stands at 3.57%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.

Negative EPS growth while VALMT.HE is at 3.33%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.

Negative diluted EPS growth while VALMT.HE is at 3.33%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.

Share count expansion well above VALMT.HE's 0.02%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.

Diluted share count expanding well above VALMT.HE's 0.02%. Michael Burry would fear significant dilution to existing owners' stakes.

No Data available this quarter, please select a different quarter.

Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.

Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.

10Y revenue/share CAGR under 50% of VALMT.HE's 92.13%. Michael Burry would suspect a lasting competitive disadvantage.

5Y revenue/share CAGR at 50-75% of VALMT.HE's 16.62%. Martin Whitman would worry about a lagging mid-term growth trajectory.

Negative 3Y CAGR while VALMT.HE stands at 13.47%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.

Negative 10Y OCF/share CAGR while VALMT.HE stands at 139.28%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.

Negative 5Y OCF/share CAGR while VALMT.HE is at 338.08%. Joel Greenblatt would question the firm’s operational model or cost structure.

Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.

Negative 10Y net income/share CAGR while VALMT.HE is at 349.90%. Joel Greenblatt sees a major red flag in long-term profit erosion.

Negative 5Y net income/share CAGR while VALMT.HE is 21.13%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.

Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.

10Y equity/share CAGR at 50-75% of VALMT.HE's 167.18%. Martin Whitman would note a lag in capital accumulation vs. the competitor.

Below 50% of VALMT.HE's 116.46%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.

Below 50% of VALMT.HE's 72.78%. Michael Burry suspects a serious short-term disadvantage in building book value.

10Y dividend/share CAGR at 50-75% of VALMT.HE's 384.81%. Martin Whitman suspects the firm lags in returning cash to shareholders over the decade.

Negative 5Y dividend/share CAGR while VALMT.HE stands at 2.27%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.

Inventory growth well above VALMT.HE's 2.30%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.

Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.

We have a declining book value while VALMT.HE shows 2.16%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.

Debt growth far above VALMT.HE's 2.23%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.

SG&A growth well above VALMT.HE's 5.95%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.